Literature DB >> 1336062

Lidocaine block of human heart sodium channels expressed in Xenopus oocytes.

M Chahine1, L Q Chen, R L Barchi, R G Kallen, R Horn.   

Abstract

The tertiary amine lidocaine is used clinically for preventing cardiac arrhythmias, and has been widely studied on mammalian tissue. Xenopus oocytes were used as an expression system to study the effect of lidocaine on a sodium (Na) channel, derived from a full-length human heart (hH1) cDNA clone. The concentration dependence of the lidocaine block of hH1 Na current was consistent with a binding stoichiometry of 1:1. At low frequency stimulation, and at holding potentials < or = 100 mV, the IC50 was 226 microM, comparable to values found in mammalian cardiac cells. Lidocaine also shifted the steady-state inactivation of hH1 Na current to hyperpolarized potentials in a dose-dependent manner. Our experiments suggest that lidocaine block is state dependent, with high affinity for an inactivated state (KI = 11 microM) and low affinity for the resting state (KR = 3.9 mM). The quaternary amine derivative of lidocaine, QX-314, had no effect on Na current at an extracellular concentration of 1 mM.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1336062     DOI: 10.1016/0022-2828(92)93090-7

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  15 in total

1.  Evidence for dimerization of dimers in K+ channel assembly.

Authors:  L Tu; C Deutsch
Journal:  Biophys J       Date:  1999-04       Impact factor: 4.033

2.  Coexisting mutations/polymorphisms of the long QT syndrome genes in patients with repaired Tetralogy of Fallot are associated with the risks of life-threatening events.

Authors:  Shuenn-Nan Chiu; Mei-Hwan Wu; Ming-Jai Su; Jou-Kou Wang; Ming-Tai Lin; Chien-Chih Chang; Hui-Wen Hsu; Ching-Tsuen Shen; Olivier Thériault; Mohamed Chahine
Journal:  Hum Genet       Date:  2012-03-11       Impact factor: 4.132

3.  Differences in steady-state inactivation between Na channel isoforms affect local anesthetic binding affinity.

Authors:  S N Wright; S Y Wang; R G Kallen; G K Wang
Journal:  Biophys J       Date:  1997-08       Impact factor: 4.033

4.  Y1767C, a novel SCN5A mutation, induces a persistent Na+ current and potentiates ranolazine inhibition of Nav1.5 channels.

Authors:  Hai Huang; Silvia G Priori; Carlo Napolitano; Michael E O'Leary; Mohamed Chahine
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-11-12       Impact factor: 4.733

5.  Fluoxetine blocks Nav1.5 channels via a mechanism similar to that of class 1 antiarrhythmics.

Authors:  Hugo Poulin; Iva Bruhova; Quadiri Timour; Olivier Theriault; Jean-Martin Beaulieu; Dominique Frassati; Mohamed Chahine
Journal:  Mol Pharmacol       Date:  2014-07-15       Impact factor: 4.436

6.  Truncated K+ channel DNA sequences specifically suppress lymphocyte K+ channel gene expression.

Authors:  L Tu; V Santarelli; C Deutsch
Journal:  Biophys J       Date:  1995-01       Impact factor: 4.033

7.  Characterization of novel KCNH2 mutations in type 2 long QT syndrome manifesting as seizures.

Authors:  Dagmar I Keller; Julie Grenier; Georges Christé; Frédérique Dubouloz; Stefan Osswald; Marijke Brink; Eckhard Ficker; Mohamed Chahine
Journal:  Can J Cardiol       Date:  2009-08       Impact factor: 5.223

8.  A new C-terminal hERG mutation A915fs+47X associated with symptomatic LQT2 and auditory-trigger syncope.

Authors:  Georges Christé; Olivier Thériault; Mohamed Chahine; Gilles Millat; Claire Rodriguez-Lafrasse; Robert Rousson; Isabelle Deschênes; Eckhard Ficker; Philippe Chevalier
Journal:  Heart Rhythm       Date:  2008-08-31       Impact factor: 6.343

9.  Antagonism of lidocaine inhibition by open-channel blockers that generate resurgent Na current.

Authors:  Jason S Bant; Teresa K Aman; Indira M Raman
Journal:  J Neurosci       Date:  2013-03-13       Impact factor: 6.167

10.  Functional expression and properties of the human skeletal muscle sodium channel.

Authors:  M Chahine; P B Bennett; A L George; R Horn
Journal:  Pflugers Arch       Date:  1994-05       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.